UK to pay for private heart treatment:
This article was originally published in Clinica
The UK government has announced that NHS heart patients will, from July 2002, have the choice of being treated in a private centre, in the UK or abroad, as part of an initiative to reduce surgery waiting lists. The initiative - the highlight of the government discussion paper Extending Choice to Patients, published last week - will affect some 14,500 patients at a cost of around £100 million ($142 million).
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.